Geri-Michelle McShane - 07 May 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: SVP, CAO
Issuer ticker: XYL
Reported as of: 07 May 2026
Net transaction value: -$501,437
SEC form: 4
Accepted by SEC: 08 May 2026, 16:15:23 UTC
Prior SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Geri-Michelle McShane

Key filing fact

Geri-Michelle McShane filed Form 4 for Xylem Inc. (XYL) on 08 May 2026.

Key facts

This page summarizes Geri-Michelle McShane's Form 4 filing for Xylem Inc. (XYL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 May 2026, 16:15.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: -$501,437.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001769064 Primary reporting owner

McShane Geri-Michelle

Relationship: SVP, CAO
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Geri-Michelle McShane
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Options Exercise

Transaction value
Shares: -3,147
Change %: -29%
Price: $86.76^*
Shares after: 7,874
Date: 07 May 2026
Ownership: Direct

XYL transaction

Common Stock

Sale

Transaction value: $501,437
Shares: -4,269
Change %: -54%
Price: $117.46
Shares after: 3,605
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,147
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,147
Exercise price: $86.76
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,269 Shares were executed at a range of prices from $117.42 to $118.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Footnote F2

The March 1, 2022 option grant vested 1,049 options on March 1, 2023, 1,049 options on March 1, 2024, and 1,049 options on March 1, 2025.